Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial

Emi Yamazaki; Taku Fujimura; Manami Takahashi-Watanabe; Satsuki Tada; Chisako Kitayama; Ryo Amagai; Yumi Kambayashi; Masahiro Watanabe; Masamitsu Maekawa; Nariyasu Mano; Yoshihide Asano

doi:10.1093/bjd/ljae343

Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial

Emi Yamazaki, Taku Fujimura, Manami Takahashi-Watanabe, Satsuki Tada, Chisako Kitayama, Ryo Amagai, Yumi Kambayashi, Masahiro Watanabe, Masamitsu Maekawa, Nariyasu Mano, Yoshihide Asano

Tohoku University

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

1 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	167-169
ページ数	3
ジャーナル	British Journal of Dermatology
巻	192
号	1
DOI	https://doi.org/10.1093/bjd/ljae343
出版ステータス	出版済み - 2024 12月 23

文献へのアクセス

10.1093/bjd/ljae343

他のファイルとリンク

引用スタイル

Yamazaki, E., Fujimura, T., Takahashi-Watanabe, M., Tada, S., Kitayama, C., Amagai, R., Kambayashi, Y., Watanabe, M., Maekawa, M., Mano, N., & Asano, Y. (2024). Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial. British Journal of Dermatology, 192(1), 167-169. https://doi.org/10.1093/bjd/ljae343

Yamazaki, Emi ; Fujimura, Taku ; Takahashi-Watanabe, Manami その他. / Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies : post hoc study of the TM5614-MM trial. In: British Journal of Dermatology. 2024 ; Vol. 192, No. 1. pp. 167-169.

@article{8cf6f687753044c5b137607b6aa477f8,

title = "Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial",

author = "Emi Yamazaki and Taku Fujimura and Manami Takahashi-Watanabe and Satsuki Tada and Chisako Kitayama and Ryo Amagai and Yumi Kambayashi and Masahiro Watanabe and Masamitsu Maekawa and Nariyasu Mano and Yoshihide Asano",

year = "2024",

month = dec,

day = "23",

doi = "10.1093/bjd/ljae343",

language = "English",

volume = "192",

pages = "167--169",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "1",

}

Yamazaki, E, Fujimura, T, Takahashi-Watanabe, M, Tada, S, Kitayama, C, Amagai, R, Kambayashi, Y, Watanabe, M, Maekawa, M , Mano, N & Asano, Y 2024, 'Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial', British Journal of Dermatology, vol. 192, no. 1, pp. 167-169. https://doi.org/10.1093/bjd/ljae343

Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial. / Yamazaki, Emi; Fujimura, Taku; Takahashi-Watanabe, Manami その他.
In: British Journal of Dermatology, Vol. 192, No. 1, 23.12.2024, p. 167-169.

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

TY - JOUR

T1 - Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies

T2 - post hoc study of the TM5614-MM trial

AU - Yamazaki, Emi

AU - Fujimura, Taku

AU - Takahashi-Watanabe, Manami

AU - Tada, Satsuki

AU - Kitayama, Chisako

AU - Amagai, Ryo

AU - Kambayashi, Yumi

AU - Watanabe, Masahiro

AU - Maekawa, Masamitsu

AU - Mano, Nariyasu

AU - Asano, Yoshihide

PY - 2024/12/23

Y1 - 2024/12/23

UR - http://www.scopus.com/inward/record.url?scp=85214319936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85214319936&partnerID=8YFLogxK

U2 - 10.1093/bjd/ljae343

DO - 10.1093/bjd/ljae343

M3 - Article

C2 - 39215562

AN - SCOPUS:85214319936

SN - 0007-0963

VL - 192

SP - 167

EP - 169

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -

Yamazaki E, Fujimura T, Takahashi-Watanabe M, Tada S, Kitayama C, Amagai R その他. Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial. British Journal of Dermatology. 2024 12月 23;192(1):167-169. doi: 10.1093/bjd/ljae343